STE STERIS
STERIS earnings company data as of 4:45 AM ET 11/6
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2027 Q2 | 4 Nov | EPS | 2.68 | — | — |
| Rev | $1.56B | $1.59B | Beat +1.8% |
Insider trades
Open-market buys and sales by STE's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $8.6M sold by 6 insiders outside a trading plan
- $1.2M sold by 2 insiders under 10b5-1 plans
-
Mohsen Sohi DirectorSale$957K 4,058 shares at $235.78 14% of stakeTraded Aug 12 Filed Aug 12
-
John Adam Zangerle Sr. VP, Gen Counsel, and Sec.Planned sale$297K 1,419 shares at $209.28 3.9% of stakeTraded Jun 15 Filed Jun 16
-
Daniel A Carestio CEOPlanned sale$947K 4,428 shares at $213.82 6.5% of stakeTraded Jun 4–5 Filed Jun 8
-
Richard C Breeden DirectorSale$310K 1,481 shares at $209.51 3.7% of stakeTraded Jun 2 Filed Jun 4
-
Cynthia L Feldmann DirectorSale$735K 3,098 shares at $237.21 82% of stakeTraded Mar 5 Filed Mar 6
-
Julia Madsen Sr. VP and GM, Life SciencesSale$1.3M 5,008 shares at $262.00 32% of stakeTraded Nov 21, 2025 Filed Nov 25, 2025
-
Renato Tamaro V.P. & Corporate TreasurerSale$1.3M 5,036 shares at $257.55 47% of stakeTraded Nov 18, 2025 Filed Nov 20, 2025
-
John Adam Zangerle Sr. VP, Gen Counsel, and Sec.Sale$4M 15,000 shares at $265.14 31% of stakeTraded Nov 11, 2025 Filed Nov 13, 2025
Also filed in the last 12 months, not counted as buying or selling: 33 share withholdings for taxes, 10 stock grants, and 9 option exercises.
SEC filings
Recent issuer filings from EDGAR, 10 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon